Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice-Reference-Cited by-同舟云学术

Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice

Published:2009-09-25 Issue:8 Volume:183 Page:5146-5157
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Araki Manabu,Chung Denise,Liu Sue,Rainbow Daniel B.,Chamberlain Giselle,Garner Valerie,Hunter Kara M. D.,Vijayakrishnan Lalitha,Peterson Laurence B.,Oukka Mohamed,Sharpe Arlene H.,Sobel Raymond,Kuchroo Vijay K.,Wicker Linda S.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Nonobese diabetic mice and the genetics of diabetes susceptibility

2. Genetic susceptibility to type 1 diabetes

3. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

4. Localization of a Type 1 Diabetes Locus in the IL2RA/CD25 Region by Use of Tag Single-Nucleotide Polymorphisms

5. Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spontaneous immunological activities in the target tissue of vitiligo-prone Smyth and vitiligo-susceptible Brown lines of chicken;Frontiers in Immunology;2024-04-24

2. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure;Annual Review of Pharmacology and Toxicology;2021-01-06

3. Overcoming Cancer Tolerance with Immune Checkpoint Blockade;Cancer Immunology;2020-09-25

4. CTLA-4: From mechanism to autoimmune therapy;International Immunopharmacology;2020-03

5. The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity;Cell Research;2020-01-23